Download FREE Report Sample
Download Free sampleUrticaria is commonly known as rubella. It is a localized edema response due to dilation of the skin and mucosal small blood vessels and increased permeability. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of the disease is delayed for several days to several months. More common in clinically.
Urticaria Drug Market contains market size and forecasts of Urticaria Drug in global, including the following market information:
Global Urticaria Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Urticaria Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Urticaria Drug companies in 2021 (%)
The global Urticaria Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acute Urticaria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urticaria Drug include Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech and Xolair, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urticaria Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urticaria Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, by Type, 2021 (%)
Acute Urticaria
Chronic Urticaria
Global Urticaria Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Urticaria Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urticaria Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Urticaria Drug revenues share in global market, 2021 (%)
Key companies Urticaria Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Urticaria Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson Services
Amneal Pharmaceuticals
Pfizer
Taro Pharmaceutical Industries Novartis AG
Akorn
Teva Pharmaceutical Industries
Genentech
Xolair
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
